Frontlight ResearchEarly access
Sjögren's disease trials in South Korea
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleTwo Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Where
- Bundang Gu, Gwangju, Seoul, Suwon
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00 - Phase 3Taking peopleA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Where
- Seoul
- Age
- 18 years and over
- People
- 844 worldwide
- Run by
- Amgen
See details and how to joinNCT06747949 · EU 2024-517513-32-00